Nakashima Y, Horie I, Arimori H, Ueda M, et al. Real-world clinical experience of reduced-dose initiation of lenvatinib in Japanese patients with radioiodine-refractory differentiated thyroid cancer. Endocr J 2025 Sep 4. doi: 10.1507/endocrj.EJ25-0251.
PMID: 40903290